PREeclampsia risk stratification test: development of a suitable CALIbration framework for the analysis of a multiplex panel of endogenous compounds by LC-MS

Projektinformationen

PRECALI

ID Finanzhilfevereinbarung: 789083

DOI 10.3030/789083

Projekt abgeschlossen

EK-Unterschriftsdatum 24 April 2018

Startdatum 1 Juni 2018

Enddatum 31 Mai 2020

Finanziert unter

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Gesamtkosten € 175 866,00

EU-Beitrag € 175 866,00

Koordiniert durch

METABOLOMIC DIAGNOSTICS LIMITED
Ireland

Veröffentlichungen

Conference proceedings (2)

Evaluation of an Artificial Serum as a Surrogate Matrix for Calibration Samples for a Preeclampsia Risk Prediction Test

Autoren: Anna Catharina Suhr, Leslie Walter Brown, Isabel Vega-Carrascal, Paloma Muñiz-Ortea, Robin Tuytten
Veröffentlicht in: 2019
Herausgeber: MSACL 2019 EU

Preeclampsia Risk Stratification: Moving from Translational Research to a Dedicated Quantitative LC-MS/MS Assay for Clinical Application

Autoren: Anna Catharina Suhr (1), Leslie Walter Brown (1), Isabel Vega-Carrascal (1), Grégoire Thomas (1,2), Fergus McCarthy (3,6), Louise Kenny (4,6), Philip Baker (5,6), Robin Tuytten (1,6) (1) Metabolomic Diagnostics, Cork, Ireland; (2) SQU4RE, Lokeren, Belgium; (3) Irish Centre for Fetal and Neonatal Translational Research, Cork, Ireland; (4) Faculty of Health & Life Sciences, University of Liverpool,
Veröffentlicht in: 2020
Herausgeber: MSACL 2020 US